- Jan 17, 2023
New drug combination may effectively treat often fatal childhood brain tumor
Researchers at the University of Colorado Anschutz Medical Campus and partners become first to treat MYC amplified Medulloblastoma on a...
- Jan 12, 2023
New Drug Shows ‘Encouraging’ Outcomes for Pediatric Brain Tumor Treatment
Treatment with tovorafenib led to a 64% overall response rate in patients with recurrent or progressive pediatric low-grade glioma, study...
- Jan 11, 2023
Genetic variant linked with increased risk of anthracycline-related cardiomyopathy
In results published in the Journal of Clinical Oncology, researchers from the University of Alabama at Birmingham discovered an...
- Jan 9, 2023
Two-year-old Millbrook boy’s cancer journey featured in charity’s 2023 calendar
As outlined in Ezra’s story, featured in Ontario Parents Advocating for Children with Cancer (OPACC)’s 2023 wall calendar, the Gulliver...
- Jan 6, 2023
Drug Response Study of Leukemia Subtypes Advances Precise Patient-Therapy Matching
A study by researchers at St. Jude Children’s Research Hospital delving into drug response across a swath of genetic subtypes of acute...